TP53 and breast cancer: Analysis of primary mammary tumors from Brca1−/−; p53+/− mice showed that multiple genetic/molecular alterations occurred during mammary tumorigenesis, including overexpression of ErbB2, c-Myc, p27 and Cyclin D1, and the loss of ERα and p16 expression [29].